Selective Glucocorticoid Receptor Agonist - Potential Applications

Potential Applications

In chronic inflammatory diseases of the skin like atopic dermatitis, the side-effects of corticoids are problematic because of the necessary long-term treatment. Therefore, SEGRAs are being investigated as an alternative topical treatment. Systemic long-term treatment of inflammations with corticoids is particularly liable to cause metabolic side-effects, which makes the development of oral SEGRAs an interesting goal. Inflammatory diseases of the eye are also a potential application because corticoids can promote glaucoma, cataract, and eye infections. It remains to be seen whether selective receptor agonists cause significantly less side-effects than classical corticoids in clinical application.

The atrophic effects of glucocorticoids are not always a disadvantage. The treatment of hyperproliferative diseases like psoriasis makes use of this property. SEGRAs would likely be less effective in such conditions.

Read more about this topic:  Selective Glucocorticoid Receptor Agonist

Famous quotes containing the word potential:

    “A child is born with the potential ability to learn Chinese or Swahili, play a kazoo, climb a tree, make a strudel or a birdhouse, take pleasure in finding the coordinates of a star. Genetic inheritance determines a child’s abilities and weaknesses. But those who raise a child call forth from that matrix the traits and talents they consider important.”
    —Emilie Buchwald (20th century)